Clinical Trials for Biofrontera

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Biofrontera

Clinical Trials (6)

NCT07053852
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
PHASE1Recruiting
10 participants
Started: Jun 27, 2025 · Completed: Feb 1, 2026
2 conditions3 sponsors1 location
NCT06577311
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
PHASE2Recruiting
20 participants
Started: Aug 14, 2024 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT06745999
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
PHASE4Recruiting
40 participants
Started: May 3, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05662202
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
PHASE3Active, not recruiting
172 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor14 locations
NCT05080764
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
PHASE2Active, not recruiting
126 participants
Started: Dec 10, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor9 locations
NCT03573401
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
PHASE3Active, not recruiting
187 participants
Started: Sep 25, 2018 · Completed: Feb 28, 2029
1 condition1 sponsor18 locations